Aroken Pharma Limited Liability Partnership - Company Profile

It is a business services limited liability partnership based in Bangalore South, Karnataka, India, established in 2024.
2024 Bangalore South, Karnataka, India Active
Last Updated:
Access Report
About Aroken Pharma Limited Liability Partnership

Aroken Pharma Limited Liability Partnership, a active limited liability partnership, was established on 29 May 2024 in Bangalore South, Karnataka, India. it holds LLPIN: ACH-4244. Registered under ROC Roc Bangalore. It has total obligation of contribution of ₹20.00 K .

Formerly known as Aroken Pharma Limited Liability Partnership. Its leadership includes Satwik Basavaraj Metgud (Designated Partner), Priyanka Patil (Designated Partner). Past directors included Sheela Kotegoudar, Akshay Basavaraj Metgud, Chaitanya Paris Khemalapure. Its latest date of accounts and solvency statement 31 March 2025. It is based at Provident Sunworth, Phase 2, 5K Block,, 704, 7Th Floor, Behind Rr Medical College, Kengeri, Bangalore South, Karnataka, 560060.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    ACH-4244

  • Incorporation Date

    29 May 2024

  • Total Obligation of Contribution

    ₹20.00 K

  • ROC Code

    Roc Bangalore

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 20.00 K
  • Company Age 1 Year 9 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Aroken Pharma Limited Liability Partnership

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aroken Pharma Limited Liability Partnership — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aroken Pharma Limited Liability Partnership?
Current Designated Partners
Name Designation Appointment Date Status
Satwik Basavaraj Metgud Designated Partner 29 May 2024 Current
Priyanka Patil Designated Partner 29 May 2024 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Partner - Past
Pramod Abcsdd Partner - Past
Pramod Abcsdd Partner - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aroken PharmaLiability Partnership.
Aroken PharmaLiability Partnership revenue growth over time
Aroken PharmaLiability Partnership profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aroken PharmaLiability Partnership?

Unlock access to Aroken PharmaLiability Partnership's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Aroken PharmaLiability Partnership?

Unlock and access historical data on people associated with Aroken PharmaLiability Partnership, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aroken PharmaLiability Partnership, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aroken PharmaLiability Partnership's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aroken PharmaLiability Partnership
Recent Activity within the Organization
  • Annual General Meeting

    Aroken Pharma Limited Liability Partnership last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    Progress on Aroken Pharma Limited Liability Partnership has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was documented.

  • Director Appointment

    Progress on Satwik Basavaraj Metgud was appointed as a Designated Partner was appointed as a Designated Partner on 29 May 2024 & has been associated with this company since 1 year 9 months . was documented.

  • Director Appointment

    The activity Priyanka Patil was appointed as a Designated Partner was appointed as a Designated Partner on 29 May 2024 & has been associated with this company since 1 year 9 months . was completed.

  • LLP Incorporation

    Aroken Pharma Limited Liability Partnership was registered on 29 May 2024 with Roc Bangalore & aged 1 year 9 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Aroken Pharma Limited Liability Partnership?

The LLPIN of Aroken Pharma Limited Liability Partnership is ACH-4244.

Where is Aroken Pharma Limited Liability Partnership headquartered?

Aroken Pharma Limited Liability Partnership is headquartered at Provident Sunworth, Phase 2, 5K Block,, 704, 7Th Floor, Behind Rr Medical College, Kengeri, Bangalore South, Karnataka, 560060.

When was Aroken Pharma Limited Liability Partnership incorporated?

Aroken Pharma Limited Liability Partnership was incorporated on 29 May 2024.

Who are the current directors of Aroken Pharma Limited Liability Partnership?

The current directors of Aroken Pharma Limited Liability Partnership are

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available